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Abstract
Background: Tumorigenic transformation of human epithelial cells in vitro has been described experimentally as
the potential result of spontaneous immortalization. This process is characterized by a series of cell–state transitions, in
which normal epithelial cells acquire first a senescent state which is later surpassed to attain a mesenchymal stem–like
phenotype with a potentially tumorigenic behavior. In this paper we aim to provide a system–level mechanistic
explanation to the emergence of these cell types, and to the time–ordered transition patterns that are common to
neoplasias of epithelial origin. To this end, we first integrate published functional and well–curated molecular data of
the components and interactions that have been found to be involved in such cell states and transitions into a
network of 41 molecular components. We then reduce this initial network by removing simple mediators (i.e., linear
pathways), and formalize the resulting regulatory core into logical rules that govern the dynamics of each of the
network components as a function of the states of its regulators.
Results: Computational dynamic analysis shows that our proposed Gene Regulatory Network model recovers exactly
three attractors, each of them defined by a specific gene expression profile that corresponds to the epithelial,
senescent, and mesenchymal stem–like cellular phenotypes, respectively. We show that although a mesenchymal
stem–like state can be attained even under unperturbed physiological conditions, the likelihood of converging to this
state is increased when pro–inflammatory conditions are simulated, providing a systems–level mechanistic
explanation for the carcinogenic role of chronic inflammatory conditions observed in the clinic. We also found that
the regulatory core yields an epigenetic landscape that restricts temporal patterns of progression between the steady
states, such that recovered patterns resemble the time–ordered transitions observed during the spontaneous
immortalization of epithelial cells, both in vivo and in vitro.
Conclusion: Our study strongly suggests that the in vitro tumorigenic transformation of epithelial cells, which
strongly correlates with the patterns observed during the pathological progression of epithelial carcinogenesis in vivo,
emerges from underlying regulatory networks involved in epithelial trans–differentiation during development.
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Background
Nearly 84% of cancers diagnosed in human adults are car-
cinomas (i.e., cancer of epithelial origin). Although epithe-
lial carcinogenesis has been strongly associated with a
chronic inflammatory process and aging [1], the precise
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role of these two processes to the origin and progression of
carcinomas remains elusive. The current general assump-
tion is that aging and inflammation increase the chance
of accumulating somatic mutations, and that this genetic
instability constitutes the cause of carcinoma. But this
view does not explain several well–described experi-
mental and clinical observations. For instance, cancer
behavior can be acquired in the absence of mutations
through trans–or de–differentiation and is characterized
for recapitulating embryonic processes. Cancer cells can
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be “normalized” by several experimental means and com-
monly show morphological and transcriptional conver-
gence despite their diverse origin and mutations [2–4]. In
addition, different carcinomas share similar time–ordered
patterns of progression, as well as clear associations with
lifestyle factors in many cases [5]. These empirical obser-
vations suggest that, in analogy to normal development,
epithelial carcinogenesis is a consequence of conserved or
generic system–level mechanisms that restrict the malig-
nant phenotypes that can be attained, as well as the
temporal patterns of progression that describe the transi-
tions between them. In accordance with this latter view,
it has been proposed that cancer can be considered a
developmental disease [6].
In agreement with this developmental view of can-
cer, numerous experimental findings in molecular and
cell biology of cancer research have revealed that it is
possible to recover cells with cancer–like phenotypes
through the induction of de–differentiation events. This
has been shown particularly in carcinomas [3, 7], since
inflammatory cytokines induce a de–differentiation event
of epithelial cells denominated Epithelial–Mesenchymal
Transition (EMT) in which cells acquire a mesenchymal
stem–like phenotype with a tumorigenic potential able to
develop cancer in mice [3].
In systems biology it is common to study cell differentia-
tion processes that underlie development and pathogene-
sis from the point of view of dynamical systems theory. In
this framework, the information encoded by the genome,
in addition to epigenetic mechanisms, can be mapped
to a gene regulatory network (GRN), that shows mul-
tiple stable steady states, each of which corresponds to
a particular phenotypic cellular state. Further, the GRN
also underlies the epigenetic landscape (EL), that restricts
the time–ordered patterns of transition between the phe-
notypes [8–13]. Thus, the same genome and GRN can
robustly generate multiple discrete cellular phenotypes
through developmental dynamics [11, 14, 15]. These sta-
ble phenotypic states are called attractors and correspond
to configurations of gene or protein activation states
that underlie the cellular fates or phenotypes. Therefore,
dynamic developmental processes – particularly, cellu-
lar differentiation and morphogenetic patterning – can
be formalized in temporal terms as transitions between
attractors (i.e., cell states). Here, we adopt such approach
to study how tumorigenic transformation due to sponta-
neous immortalization via EMT emerges from the regula-
tory interactions between different molecular players that
are known to contribute to the tumorigenic transforma-
tion of epithelial cells. We hypothesize that: (1) a generic
series of cell state transitions describing the phenotypic
transformation of epithelial cells first to senescent cells
and finally to mesenchymal stem–like cells, that is widely
observed in epithelial cell cultures during spontaneous
immortalization, naturally result from the self–organized
behavior emerging from an underlying intracellular GRN;
and (2) that pro–inflammatory tissue–level conditions,
which are associated with a bad prognosis, increase the
likelihood of this tumorigenic process, promoting the
emergence and progression of epithelial cancer.
To test our hypothesis, we propose here a cellular–level
GRN that, for the first time, integrates those molecular
components and their interactions that have been exper-
imentally shown to play an important role during the
emergence and progression of carcinomas. It includes the
key molecular regulators that: (1) characterize the cellu-
lar phenotypes of epithelial, mesenchymal stem–like, and
senescent cells; (2) are involved in the induction of the cel-
lular processes of replicative senescence, cellular inflam-
mation, and epithelial–mesenchymal transition (EMT);
and (3) are involved in the phenotypic changes undergone
by cells emerging from these processes (i.e., mesenchymal
stem–like cells). We then obtained a reduced regulatory
core for further dynamical analyses by removing linear
cascades while maintaining the feedback loops. We show
that the proposed regulatory core module displays an
orchestrating robust behavior akin to that seen in other
developmental regulatory modules previously character-
ized with similar modeling approaches (see, for example
[8, 9, 16, 17]). Specifically, by proposing logical func-
tions grounded on the available experimental data for this
regulatory core module, and by analyzing its behavior fol-
lowing conventional BooleanGRNdynamical approaches,
we show that the uncovered GRN converges to exactly
the three attractors corresponding to the expected gene
expression configurations characterizing the epithelial,
senescent, and mesenchymal stem-like phenotypes. Addi-
tionally, using a stochastic version of the model to explore
the GRN EL (following the methodology proposed in
[13]), we found that the proposed GRN also explains the
commonly observed temporal sequence by which epithe-
lial cells acquire the potentially tumorigenic mesenchymal
stem–like phenotype.
Our results suggest that the proposed core GRN incor-
porates a set of necessary and sufficient components and
interactions to explain the emergence of gene configura-
tions characteristic of epithelial, senescent and mesenchy-
mal cells, as well as the time–ordered sequence of cellular
transformations observed in the spontaneous immortal-
ization process that, in turn, underlies the tumorigenic
transformation of epithelial cells.
Results
Gene regulatory network underlying spontaneous
immortalization
Following a bottom–up approach, we performed an
extensive literature search to gather the most relevant
experimental functional molecular data describing the
Méndez-López et al. BMC Systems Biology  (2017) 11:24 Page 3 of 15
cellular–level processes involved in epithelial carcinogen-
esis, namely: replicative cellular senescence, inflamma-
tion, and EMT (see Additional file 1: Table S4). We found
a set of 41 molecular players (12 TFs and 29 signaling
molecules) which are involved in epithelial or mesenchy-
mal cell differentiation, cellular inflammation, senescence,
DNA damage, cell cycle, or in epigenetic silencing; as well
as 97 regulatory interactions between them. For the first
time, we integrated this previously scattered experimen-
tal information into the GRN represented in Fig. 1a. To
further support that the set of regulatory interactions that
we manually curated based on published data are indeed
representative of the cellular–level processes underlying
epithelial carcinogenesis, we performed a network–based
Gene Set Enrichment Analysis (GSEA) of the GRN, using
both the KEGG and the GO Biological Process databases
as reference. We found that among the 12 pathways or
processes reported as significant when taking the KEGG
database as a reference, 10 (≈ 83%) correspond to the
cancer types bladder cancer, chronic myeloid leukemia,
non-small cell lung cancer, glioma, melanoma, pancre-
atic cancer, prostate cancer, small cell lung cancer, thyroid
cancer, from which 6 (66.6%) correspond to carcinomas.
When taking the GO Biological Process database as ref-
erence, we found that the molecules considered in our
regulatory network are significantly enriched for several
of the biological processes known to play important roles
during spontaneous immortalization of epithelial cells,
namely replicative senescence, cellular senescence, cell
aging, positive regulation of ephitelial to mesenchymal
transition determination of adult life span, among oth-
ers (Table 1). Additionally to these GSEA, we performed
a Network-based topological gene set enrichment analy-
sis (described in Methods) and found that, in addition to
the enrichment of the pathways and processes described
above, the molecules in the proposed network show
also a topological signature that strongly resembles the
structure of the cancer pathways included in the KEGG
database (see Additional file 2: Figure S1). The com-
plete enrichment results are included in Additional file 3:
Supplementary Tables. These results provide further sup-
port for the relevance of the proposed molecular players,
manually assembled from an exhaustive literature search,
and for the novel regulatory module proposed here.
In conclusion, based on these analyses and the cur-
rent state of knowledge according to annotated databases,
the set of molecules manually included in the proposed
large network seem to be representative of the cellular
phenotypes and processes considered as prior biologi-
cal knowledge in our model. In addition, the molecular
components included in the proposed network are tightly
associated with reference pathways of epithelial cancers.
Additionally, robustness analysis performed on the net-
work showed that the recovered attractors are also robust
to permanent alterations of the regulatory logic (see
Additional file 4: Text).
To study the dynamic and steady–state properties of the
network underlying epithelial carcinogenesis, we reduced
the initial network (Fig. 1a) into a more mathematically
and computationally tractable regulatory core network by
collapsing the linear pathways while retaining the feed-
back loops. This reduced network, represented in Fig. 1b,
retains only the main players and regulatory interac-
tions that underlie epithelial and mesenchymal differen-
tiation, cell cycle progression, senescence, and cellular
inflammation.
Epithelial differentiation is represented by the tumor
suppressor Epithelium-Specific TF ESE–2, which acts
as a master regulator of this process by triggering the
expression of epithelium-specific genes while repressing
mesenchymal markers, such as Snail [18]. ESE–2 also pro-
motes its own expression and the expression of the other
ESE TFs [19], and it is hence considered as the main rep-
resentative of the TF family [18]. The differentiation of
epithelial cells into a mesenchymal stem–like phenotype is
orchestrated by the TF Snai2, which further induces its
own expression via the activation of Twist-Zeb-FOXC2
[20]. The progression of the cell cycle is controlled by Rb,
E2F, Cyclin, and Telomerase (here TELase). While both
E2F [21] and cyclins [22] are required for cell cycle pro-
gression, the tumor suppressor Rb acts as an inhibitor
of this process by forming an inactive heteromer with
E2F [23]. The enzyme TELase is responsible for the de
novo synthesis of telomeres, a process that allows cells
to surpass the cell cycle checkpoints and become immor-
talized [24]. Indeed, high levels of TELase are typical of
tumor initiating cells that become resistant to therapy
[3, 25]. The senescence of epithelial cells is mainly con-
trolled by the two tumor supressors p53 and p16 [26].
They both induce replicative senescence by reducing the
activity of cyclins [27] and by inducing an Rb-mediated
inhibition of E2F [28]. Cellular inflammation is char-
acterized by the increased activity of the TF NF–κB.
Many (micro)environmental stimuli, including pathogens,
cytokines, interleukins, and antigens; trigger the expres-
sion of NF–κB, resulting in an immune response
characterized by increased levels of cytokines and
enzymes such as phospholipase A2, cyclooxygenase, and
lipoxygenase [29].
The above described molecular players (ESE–2, Snai2,
Rb, E2F, cyclin, TELase, p53, p16, and NF–κB) are tightly
interconnected by the following regulatory interactions:
NF–κB positively controls its own expression via the
induction of pro-inflammatory cytokines [30, 31]. It also
promotes the epithelial and mesenchymal stem–like phe-
notype by positive interactions with ESE–2 [32] and Snai2
[33], respectively; and it induces the cell cycle process by
increasing cyclin [34] and inhibiting p53 expression [35].
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Fig. 1 Gene Regulatory Network underlying spontaneous immortalization. a Gene regulatory network for epithelial carcinogenesis. b A Core
Regulatory Network Module Underlying Spontaneous Immortalization and Epithelial–Mesenchymal Transition. c Predicted gene expression profiles
characterizing the epithelial, senescent and mesenchymal stem–like cells. d Cellular inflammation increases the size of the basin of attraction of the
mesenchymal stem–like phenotype
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Table 1 Most significant pathways and processes in the GRN (Fig. 1a) shown by a network–based gene set enrichment analysis
KEGG – Pathway or Process (carcinomasmarked in italics) Functional association (XD–score) q-value Overlap/Size
Bladder cancer 1.06805 0 11/38
Chronic myeloid leukemia 0.66539 0 13/69
p53 signaling pathway 0.68435 0 12/62
Pancreatic cancer 0.53872 0 11/70
Glioma 0.57682 0 10/60
Non–small cell lung cancer 0.61604 0 9/51
Melanoma 0.55531 0 10/62
Small cell lung cancer 0.39796 0 10/82
Prostate cancer 0.43396 0 11/84
Cell cycle 0.44349 0 16/120
Cytosolic DNA–sensing pathway 0.48155 0.00001 6/40
Thyroid cancer 0.39015 0.00564 3/25
Endometrial cancer 0.31015 0.00018 5/50
GO Biological Process
Replicative senescence 3.138 0 8/10
Cellular senescence 0.738 0.01815 2/10
Cell aging 0.438 0.00461 3/24
Positive regulation of epithelial to mesenchymal transition 0.438 0.03501 2/16
Determination of adult lifespan 0.33328 0.40382 1/10
ESE–2 forms an auto–activation feedback loop, inhibits
Snai2 [18], induces cyclin, inhibits TELase [18], and acti-
vates of NF–κB [36]. Snai2 induces its own expression
[37], increases the activity of TELase [38], and decrease
the expression of the epithelial–specific TF ESE–2 [18]. It
also represses the cell cycle process by reducing the tran-
scription of cyclin [39] and E2F [40], represses cellular
senescence by decreasing the expression of p16 [41] and
p53 [42], and induces cellular inflammation by increasing
the expression of NF–κB [43]. p16 promotes its own activ-
ity forming a positive feedback loop [44], stabilizes p53 via
the inactivation of its inhibitor MDM2 [45], and inhibits
the cell cycle progression by the induction of Rb [46] and
the inhibition of cyclin [23, 28]. These molecular pro-
cesses are known to induce the senescent phenotype. p16
also contributes to the cellular inflammation observed in
senescent cells by inducing the activation of NF–κB [47].
p53 inhibits E2F [48]. Rb inhibits E2F [23]. E2F induces
cyclin [49] and inhibits the senescence marker p16 [50].
Cyclin inhibits Rb activity [51] and stimulates E2F tran-
scription [52]. Finally, TELase inhibits the senescence
markers p16 [53] and p53 [54].
To analyze its long term and dynamic properties, we
then formalized the above described regulatory interac-
tions (Fig. 1b), by translating the nodes and their cor-
responding logical interaction rules into a mechanistic
Boolean dynamical GRN model [55]. The corresponding
logical rules and truth tables can be found in the
Additional file 5: Logic rules and truth tables.
The epithelial, senescent, andmesenchymal stem–like
phenotypes are attractors of the GRN
It has been experimentally shown that during the process
of spontaneous immortalization epithelial cells acquire
first a senescent and finally a mesenchymal stem–like
cell phenotype [56], each of which can be described in
terms of their gene expression profiles. Here, we per-
formed long-term (technical term) simulations of our
Boolean model of the GRN with the aim to recover
these three characteristic expression patterns. We found
that indeed our GRN (Fig. 1b) converges to three attrac-
tors, each corresponding, respectively, to the epithe-
lial, senescent, and mesenchymal stem–like phenotypic
markers (Fig. 1c).
Epithelial cells are characterized by the high expres-
sion of the TF ESE–2, which acts as a master regulator.
Being part of a constantly renewing tissue, epithelial cells
show an increased expression of the cell cycle inducers
Cyclin and E2F and a decreased expression of the cell
cycle inhibitor Rb [57] and of the senescence markers
p53 and p16 [58]. Epithelial cells do not express TELase,
since the activity of this enzyme is inhibited in response
to induction of differentiation events [59]. Being a con-
stitutively expressed gene, epithelial cells show also high
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levels of the TF NF–κB [60]. In accordance to this empir-
ical activity profile, approximated as a Boolean vector, the
first attractor of our GRN shows an absence of activity for
p53, p16, Rb, TELase and Snai2; and presence of NF–κB,
Cyclin, E2F and ESE–2 (Fig. 1c, left).
Senescent epithelial cells conserve the high levels of
the epithelial markers ESE–2 [61] and the low expression
of the mesenchymal marker Snai2 [18]; but, in contrast
to normal epithelial cells, these cells show an increased
expression of the two tumor suppressor proteins p16
and p53 [62], both of which contribute to the cell cycle
arrest by inhibiting the cell cycle inducers Cyclins and
E2F [27, 28, 63] and by inducing the cell cycle suppres-
sor Rb [64]. As in homeostatically cycling epithelial cells,
TELase is inactive in this cell type [59]. Also in this case,
NF–κB expression is constitutively active. These features
are recovered in our second attractor, which shows activ-
ity of NF–κB, p53, p16, Rb and ESE2, and absence of
TELase, Snai2, cyclin, and E2F (Fig. 1c, center). Also in
this case, our in silico analysis predicts activity of NF–κB
in epithelial senescent cells.
Mesenchymal stem–like cells express the mesenchy-
mal marker Snai2 [18], which acts as one of the key
players during the EMT by orchestrating the repression
of epithelium–specific genes [65] such as ESE–2 [18]
and by inducing the expression of mesenchymal markers
[63]. In contrast to the senescent cells, these mesenchy-
mal stem-like cells have a strong proliferative potential,
shown by a decreased expression of p53, p16, Rb; and
by a high expression of cyclin [66]. Cell cycle progres-
sion is further promoted in these potentially tumor ini-
tiating cells by the high levels of TELase [3, 25]. This
cell type also shows a constitutive expression of NF–κB
[60, 67]. Our third attractor recovers this genetic con-
figuration, showing inactivity of p53, p16, Rb, E2F and
ESE–2; and activity of NF–κB, TELase, Snai2, and Cyclin
(Fig. 1c, right).
Cells that have acquired this latter mesenchymal stem–
like phenotype have a strong tumorigenic potential,
since they show most of the hallmarks of cancer: The
low expression of ESE–2 accompanied by the over–
activation of Snai2 enable cells to sustain proliferative
signals and to evade growth suppressors by undergoing a
de–differentiation process [68]. Further, the constitutive
activity of Snai2 is associated to an motile and invasive
phenotype, andwith the avoidance of immune destruction
[69] and deregulation of cellular energetics [70]. The de–
activation of the senescence markers p16 and p53 and of
the tumor suppressor Rb, as well as the over–expression
of TELase, confers genome instability that is associated
to a mutation–prone phenotype [71] and enable cells to
acquire replicative immortality and to resist cell death.
Moreover, high levels NF–κB suggest chronic and tumor-
promoting cellular inflammation [72].
The correspondence between the recovered attractors
in the GRN model simulation and the experimentally
observed gene or protein configurations in the studied cel-
lular phenotypes strongly suggests that the proposed core
GRN indeed constitutes a regulatory module that com-
prises a set of components and interactions able to restrict
the system to converge to the cellular states observed
during spontaneous immortalization. We conclude that
the derived core GRN module (Fig. 1b) includes a set
of sufficient and necessary molecular players and inter-
actions that specify epithelial, senescent and stem–like
mesenchymal cells.
Cellular inflammation accelerates the spontaneous
immortalization of epithelial cells
Inflammation has been recognized as one of the key
drivers of carcinogenesis, partly due to its implica-
tion in the EMT [79]. Indeed, several pro-inflammatory
cytokines such as TFG-β [80] and IL-6 [81], some of
which are produced by senescent cells [82], have shown
to be strong inducers of EMT. Cells that are exposed
to such a pro-inflammatory micro-environment show an
over-activation of NF–κB [31, 47], which induces EMT by
triggering the expression of mesenchymal markers includ-
ing Snail [20] and silences the expression of p16 and
p53 [83]. To assess whether our model reproduces this
increased propensity of de–differentiation into a mes-
enchymal stem–like phenotype in the presence of cellular
inflammation, we calculated the relative size of the basins
of attraction of the epithelial, senescent, and mesenchy-
mal stem–like phenotypes (Fig. 1c), with and without the
assumption of a constant over–activation of the NF–κB
node in the GRN model. We found that cellular inflam-
mation increases the size of the mesenchymal stem–like
attractor from 56.25 to 75% while decreasing the region
of convergence of the epithelial (from 17.97 to 6.25% )
and of the senescent (from 25.78 to 18.75% ) phenotypes
(Fig. 1d). These results are in accordance with the exper-
imental results stated above, in which cellular inflam-
mation is recognized as an important driver of spon-
taneous immortalization by promoting the induction of
de–differentiation of epithelial cells into a mesenchymal
stem–like phenotype.
The proposed GRN reproduces the characteristic
phenotypes of 6 different mutant conditions
To further validate our model, we tested if the GRN
(Fig. 1b) is able to reproduce the phenotypic con-
figurations (in the form of attractors) observed in 6
different mutant conditions. Specifically, we simulated
loss– and gain–of–function conditions of ESE–2, Snai2,
and p16 (by setting the expression state for the cor-
responding node constitutively to “1” or “0”, respec-
tively), and compared the resulting attractors to the
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corresponding gene expression profiles reported in the
literature. When simulating ESE–2 loss–of–function the
model recovers a single attractor, equivalent to a mes-
enchymal stem–like phenotype with increased Snai2
expression as experimentally observed [18] (Fig. 2a). Sim-
ulations of the ESE–2 gain of function mutant results in
three attractors that are consistent with the experimen-
tal description of the phenotypes resulting from ESE–2
over–expression: an epithelial senescent cell [61], a nor-
mal epithelial cell [18], and a EMT intermediate state
presenting simultaneous features of both epithelial and
mesenchymal states with proliferative phenotype [73]
(Fig. 2b). Simulating Snai2 loss–of–function gives rise to
two attractors corresponding to normal and senescent
epithelial phenotypes, both consistent with experimen-
tal observations [18] (Fig. 2c). Simulating Snai2 gain–
of–function mutation results in a single attractor corre-
sponding to mesenchymal stem–like phenotype, which
is also consistent with experimental observations derived
from ectopic over–expression of mesenchymal TFs [74]
(Fig. 2d). These results are also consistent with the TGF-
β-dependent induction of EMT, which occurs via the acti-
vation of Snail by downstream components of the TGF-β
signaling pathway [75], and which have been success-
fully reproduced in a recent model of TGF-β-driven EMT
[76]. p16 loss–of–function simulations recover two attrac-
tors corresponding to an epithelial and a mesenchymal
stem–like cell, which is also consistent with experimen-
tal observations [77] (Fig. 2e). Finally, gain–of–function
simulation of p16 recovered two attractors, one asso-
ciated with a mesenchymal stem–like but incompletely
senescent (due to the lack of p53) phenotype, the other
corresponding to an epithelial senescent phenotype. The
first prediction is consistent with the immortalization
and apoptosis–resistance shown by mesenchymal stem–
like cells, as well as with the capability of mesenchymal
TFs to abrogate senescence [78]. The second attractor is
consistent with the potential for replicative senescence
Fig. 2 Predicted attractors of loss – and gain of function mutants of the GRN for ESE2 (a, b), Snai2 (c, d) and p16 (e, f). Percent (%) represent the size
of the corresponding basin of attraction
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of epithelial cells [56] (Fig. 2f). In conclusion, we found
that our model simulations are consistent with six mutant
conditions reported in the literature, providing further
validation for our proposed GRN.
Attractor time–ordered transitions: epigenetic landscape
of the uncovered GRN core module
During the tumorigenic transformation of epithelial cells
in culture a generic time–ordered series of cell state
transitions is observed and can be robustly induced [3].
Normal epithelial cells become first senescent cells, a
state which they afterwards overcome to acquire a mes-
enchymal stem–like phenotype. Interestingly, during the
progressive pathological description of epithelial carcino-
mas in vivo, the temporal pattern with which each of these
different cell phenotypes enriches the tissue seems to be
tightly ordered and is also generic to all types of such
cancers irrespective of the tissue where they first appear.
In order to test if the uncovered GRN core module not
only underlies and restricts the types of cell phenotypes
(attractors) but also their time–ordered transitions, we
performed two independent EL: (1) We explored the tem-
poral sequence of attractor attainment, and (2) calculated
the consistent global ordering of all the given attractors.
To do so, we followed [13, 84] and explored the EL asso-
ciated to the GRN by implementing a discrete stochastic
model as an extension to the deterministic Boolean net-
work model [11] (detailed in Methods). The results of
our analysis regarding the temporal sequence of attrac-
tor attainment (following the methodology proposed in
[13]) show that the most probable temporal order of
attractor attainment for a population of cells that initially
show and epithelial phenotype correspond to the expected
transition from an epithelial to a senescent to a mesenchy-
mal stem–like phenotype (Fig. 3a). The estimated tran-
sition probability matrices are given in Additional file 4:
Table S1.
In agreement with these results, following [85] we found
a consistent global temporal ordering of the uncovered
attractors. This analysis is based on calculating the rela-
tive stability of the three different attractors, which is done
by computing theMean First Passage Time (MFPT, shown
in Additional file 4: Table S2) between pairs of attrac-
tors. These, in turn, epitomize barrier heights in the EL
by approximating a measure for the ease of specific tran-
sitions. Similar to the previous analysis, the uncovered
global ordering of attractors is Epithelial → Senescent
→ Mesenchymal stem–like (Fig. 3b). This path corre-
sponds to the only order in which the system can visit
the three attractors following a positive net transition rate
(Additional file 4: Table S3). These results indicate
that, when considering intracellular regulatory constraints
alone, the uncovered GRN coremodule structures the epi-
genetic landscape in a way that a specific flow across the
landscape is preferentially and robustly followed (Fig. 3c).
We anticipate that observed transition rates in vivo are
likely to be altered or favored by tissue–level processes
and/or additional GRN components underlying epithe-
lial cell sub–differentiation that have not been considered
here. These latter restrictions will be modeled in future
single cell and multi–level models building up on the
framework that has been put forward here.
Discussion
Multicellularity by definition implies a one–to–many
genotype–phenotype map. The genome of a multicellular
individual possesses the intrinsic potentiality to imple-
ment a developmental process by which all its different
cell–types and tissue structures are ultimately established.
In the last decades, a coherent theory to explain the devel-
opment of multicellular organisms as the result of the
orchestrating role of GRNs has been developed [8, 10, 11].
The main conclusion is that observable cell states emerge
from the self–consistent multi–stable regulatory logic dic-
tated by genome structure and obeyed by (mainly) TFs
resulting in stable, steady–states of gene expression. Can-
cer development and progression is also a phenomenon
intrinsic to multicellular organisms. Furthermore, simi-
lar to normal development, cancer is robustly established
as evidenced by its directionality and phenotypic con-
vergence [2]. Might also cancer be orchestrated by GRN
dynamics? Several hypothesis have been presented in this
direction such as the cancer attractor theory [2, 6], and
the endogenous molecular cellular network hypothesis
[86, 87]. In this contribution we adhere to the view-
point of an intrinsic regulatory network, but focus on a
specific developmental process at the cellular level: the
robust cell state transitions observed during the tumori-
genic transformation of human epithelial cells in culture
induced by cellular inflammation and resulting from sur-
passing a senescent state through EMT – i.e., tumorigenic
transformation due to spontaneous immortalization via
EMT [63, 88].We propose that a mechanistic understand-
ing of this process is an important first step to unravel
key cellular processes which might be occurring in vivo,
where its rate of occurrence is likely to be regulated by
tissue–level and systemic conditions directly linked with
lifestyle choices, as well as additional regulatory interac-
tions underlying epithelial cell sub–differentiation.
A generic GRN underlying the epithelial, senescent and
mesenchymal stem–like phenotypes
The predominant strategy in the molecular study of can-
cer and cellular tumorigenic transformation has been to
focus on pathways and associated mutations. Aware that
signaling pathways are actually embedded in complex
regulatory networks, here we assembled curated litera-
ture into a GRN comprising themainmolecular regulators
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Fig. 3 Temporal sequence and global order of cell–fate attainment pattern under the stochastic Boolean GRNmodel during epithelial carcinogenesis.
aMaximum probability p of attaining each attractor, as a function of time (in iteration steps). The most probable sequence of cell attainment is:
epithelial → senescent → mesenchymal stem-like. The error probability used in this case was ξ = 0.05. The same patterns were obtained with the
3 different error probabilities tested (data not shown). b Schematic representation of the possible transitions between pairs of attractors. Arrows
indicate the directionality of the transitions. Above each arrow a sign (+) or (−) indicates whether the calculated net transition rate between the
corresponding attractors is positive or negative. Red arrows represent the globally consistent ordering for the 3 attractors: the order of the attractors
in which all individual transition has a positive net rate, resulting in a global probability flow across the EL.
c Schematic representation of the time–ordered phenotype transitions along the epigenetic landscape, showing the in–between attractor barrier
highs in the landscape
involved in key cellular processes ubiquitous to carcino-
genesis, following a bottom–up approach. Subsequently,
we followed a mechanistic approach to address the ques-
tion of whether we assembled a set of sufficient and neces-
sary molecular players and interactions able to recover the
cellular phenotypes and processes documented during the
spontaneous immortalization of human epithelial cells in
culture. Thus, in this contribution, we analyzed, and val-
idated an experimentally grounded core GRN dynamical
model.
Small developmental regulatory modules have been
shown to successfully include the necessary and suffi-
cient set of components and interactions for explaining, as
manifestations of intrinsic structural and functional con-
straints imposed by these GRNs, the dynamics of complex
processes such as stem cell differentiation [89], cell–fate
decision [90] and similar cellular processes during plant
morphogenesis [8, 9, 13, 16]. We hypothesized that a sim-
ilar core developmental module can be formulated in an
attempt to explain the cell–fates observed during sponta-
neous immortalization of human epithelial cells in vitro
resulting in a potentially tumorigenic state. In order to
show this, we first reduced the proposed larger network
(Fig. 1a) into a regulatory core module, consisting of a
small set of keymolecular players and the regulatory inter-
actions between them (Fig. 1b). Although the components
of the core module have been previously shown to be
involved in EMT, the proposed architecture and topol-
ogy of this core module had not been proposed before.
We extracted from available literature the expression pro-
files of the generally observable cell states of interest in
terms of this minimal set of molecules, and tested whether
the reduced GRN, formalized into logical rules, is able
to recover the biologically observable expression pro-
files as stationary and stable network configurations (i.e.,
attractors). Indeed, we found that the core GRN model
converges exactly to the three observed gene expres-
sion profiles that correspond to the three phenotypes
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that wild type cells acquire during the process of spon-
taneous immortalization (Fig. 1c). Our model analysis
also shows that cellular inflammation increases the size
of the basin of attraction of the potentially tumorigenic
mesenchymal stem–like phenotypic attractor (Fig. 1d),
which is in agreement with the strong tumorigenic effect
of inflammation that has been consistently reported in
the experimental and clinical literature. Further, our in
silico simulations of mutant conditions are also congru-
ent with the corresponding expression profiles (Fig. 2).
These results strongly suggest that we have successfully
included the key regulators and interactions at play during
the establishment of cell steady–states observed during
the tumorigenic transformation of human epithelial cells
resulting from spontaneous immortalization.
It is noteworthy that our model does not include
any hypothetical interaction or component, a common
practice in GRN modeling [9, 16, 90]. Our GRN model
exclusively integrates available published functional
experimental data; indeed, it was a surprising result
that the observed dynamical behavior emerged naturally
under such conditions. This suggests that despite incom-
plete information, there is enough molecular data to
uncover important restrictions underlying cell behavior
during transitions relevant to epithelial carcinogenesis.
Consequently, we consider that the networks reported
herein may serve as bona fide base models useful to inte-
grate novel discoveries, as well as components underlying
epithelial cellular sub–differentiation, while following a
bottom–up approach in cancer network systems biology.
Time–ordered transitions of the phenotypic attractors
Discrete GRN models can be used to integrate regulatory
mechanisms that not only recapitulate the observed gene
expression patterns, but that also reproduce the observed
developmental time–ordering of cell phenotypes. This
can be done by considering stochasticity in the model in
order to explore [11, 17, 84] and/or characterize [85] the
associated EL. Importantly, by exploring noise–induced
transitions we do not assume that noise alone is the driv-
ing force of the transitions, instead, we exploit noise as a
tool to explore the GRN–based version of Waddington’s
EL and to indirectly characterize its multidimensional
structure. Specifically, by calculating the relative stabil-
ity of the attractors (see Methods) we approximate the
in–between attractor barrier heights in the landscape.
Furthermore, measures of relative stability can also be
exploited to calculate net transition rates measuring the
ease of specific inter–attractor transitions and to uncover
the predominant developmental path across the epige-
netic landscape [91]: ordered transitions sharing positive
net transition rates will be preferentially followed. Our
results show that such a developmental path follows the
time–order of cellular phenotypic states from epithelial,
to senescent and finally mesenchymal stem–like cells with
a tumorigenic potential (Fig. 3). In other words, the con-
straints imposed by the GRN structure the associated EL
in such a way that an epithelial cell in culture “ball” would
naturally roll following such a path, in agreement with the
observed spontaneous immortalization process (Fig. 3c).
It is interesting that the core GRN network is canal-
ized to the few steady–states and the developmental
time–ordering consistent with the molecular character-
ization of cell phenotypes observed during spontaneous
immortalization and which correlate with carcinoma pro-
gression in vivo. This suggests that specific progressive
alterations or particular “abnormal” signalingmechanisms
are not necessarily required for a cell to reach a potentially
tumorigenic state.
Conclusions
In this contribution we propose an experimentally
grounded GRN model for spontaneous immortalization.
For the first time, we integrated a wealth of empiri-
cal evidence into a GRN (41 nodes, Fig. 1a) which we
reduced to a core GRN developmental module (9 nodes,
Fig. 1b) that converges to the three phenotypes observed
during the spontaneous immortalization of epithelial
cells (Fig. 1c). Simulations of cellular inflammation lead
to an increase in the size of the basin of attraction
of the potentially tumorigenic mesenchymal stem–like
phenotype (Fig. 1d). Our model also reproduces sev-
eral experimentally reported mutant conditions (Fig. 2),
as well as the time–ordered phenotypic transitions
undergone by epithelial cells during the process of spon-
taneous immortalization (Fig. 3). The proposed GRN
constitutes thus a integrative, coherent, and experimen-
tally validated framework which can be used in the future
for the integration and analysis of additional signaling
and mechanical processes that affect, and are affected
by, the oncogenic transformation of the epithelial tissue.
To this end, first we will explicitly incorporate into the
current model EMT–inducing signaling pathways, (trig-
gered by pro-inflammatory cytokines), increased TFG-β
concentrations, or changes in the mechanical properties
of the surrounding environment. Analysing how these
pathways affect the phenotypic outcome, and how differ-
ent nutritional or pharmacological conditions modulate
these trans-differentiation processes (using for example
themethodologies proposed in [92, 93]) can aid the design
of better prevention and treatment or even oncogenic
transformation reversion strategies. To explore this com-
plex interplay between the transcriptional and signaling
events driving the phenotypic transitions in individual
cells, and the changing properties of the epithelial tis-
sue, we will develop multi-scale tissue level models. Such
a framework will enable the systematic assessment of
the role on the oncogenic process of several tissue–level
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constraints such as cell cycle progression, cell–cell inter-
actions, differential proliferation rates, as well as physical
fields (e.g., mechanical forces).
Our proposed integrative, quantitative, and dynamical
framework contributes to the understanding of the mech-
anisms underlying the onset and progression of epithelial
cancer, which is necessary for devising new and more
effective preventive strategies that halt or slow the pro-
gression of these diseases.
Methods
Construction of the network underlying epithelial
carcinogenesis
A total of 159 references, considering both references in
the main text and in the Supplementary Information [see
Additional file 1: Table S4], were carefully and manually
reviewed in order to determine a minimal set of cellular
phenotypes and processes which enable a generic repre-
sentation of spontaneous immortalization (also reported
in epithelial carcinogenesis) on the basis of cell state
transition events.
Following a bottom–up and an expert knowledge
approach we propose a set of cellular dynamical pro-
cesses ubiquitous to spontaneous immortalization (also
reported in epithelial carcinogenesis), namely: replicative
cellular senescence EMT driven by inflammation. The cel-
lular phenotypes, epithelial, senescent, and mesenchymal
stem–like produced by EMT induction have been largely
characterized as biological observables involved in such
processes. We take this information as a methodologi-
cal basis to integrate a generic dynamical network model
of spontaneous immortalization. As a first step in net-
work integration, we assembled a set of TFs and additional
molecular species involved in the establishment and regu-
lation of these cellular states and processes. Subsequently,
we manually retrieved documented regulatory interac-
tions among themolecular species, considering only those
supported by experimental evidence. The resulting nodes
and regulatory interactions were then assembled manu-
ally into the network represented in Fig. 1a with nodes
representing genes and proteins and edges representing
activating or inhibitory interactions.
Network–based gene set enrichment analysis
The bioinformatics tools EnrichNet [94] and TopoGSA
[95] were used to perform network–based gene set enrich-
ment analysis and topology–based gene set analysis,
respectively. Briefly, EnrichNet maps the input gene set
into a molecular interaction network and calculates dis-
tances between the genes and pathways/processes in a
reference database. TopoGSA also first maps the input
gene set into a reference network, to then compute its
topological statistics, to finally compare these against the
topology of pathways/processes in a reference database.
Here a connected human interactome graph extracted
from the STRING database, the KEGG and the GO Bio-
logical Process databases were used as reference molec-
ular interaction network and database, respectively. Both
analysis were performed using the Cytoscape plugin
Jepetto [96].
Network reduction
The regulatory core underlying spontaneous immortal-
ization (Fig. 1b) was obtained from the large network
(Fig. 1a) by iteratively reducing all the simplemediator (i.e.
those with in-degree and out-degree of one) and source
(those with no regulators) nodes. This reduction pro-
cess has been shown to conserve the attractors of the
original Boolean network under an asynchronous update
method [97]). During the reduction process, we kept the
main molecular players controlling cellular senescence
(p53 and p16), Cell Cycle (TELase, E2F, Rb and cyclin),
differentiation into epithelial cells (ESE-2), differentiation
into mesenchymal cells (Snai2), and cellular inflammation
(NF-κB), since different activity configurations of these
molecular players define the transcriptional identity of the
three cellular phenotypes we sought to reproduce with the
proposed model.
Dynamical gene regulatory network model
A Boolean network models a dynamical system assum-
ing both discrete–time and discrete–state variables. This
is expressed formally with the mapping:
xi(t + 1) = Fi (x1(t), x2(t), . . . , xk(t)) , (1)
where the set of functions Fi are logical propositions
(or truth tables) expressing the relationship between the
genes that share regulatory interactions with the gene
i, and where the state variables xi(t) can take the dis-
crete values 1 or 0 indicating whether the gene i is
expressed or not at a certain discrete–time t, respec-
tively. An experimentally grounded Boolean GRN model
is then completely specified by the set of genes pro-
posed to be involved in the process of interest and the
associated set of logical functions derived from exper-
imental data [17]. The set of logical functions for the
core regulatory module used in this study is given in the
Additional file 5. The dynamical analysis of the Boolean
network model was conducted using the package BoolNet
[98] within the R statistical programming environment
(www.R-project.org).
Size of the basins of attraction
The size of the basins of attraction of the GRN cor-
responds to the percentage of initial Boolean network
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configurations converging to that attractor, and were
calculated for our GRN under wt (Fig. 1d) and under dif-
ferent mutant conditions (Fig. 2) by exhaustively exploring
all the 29 = 512 possible initial configurations of the GRN.
Epigenetic Landscape characterization
Stochastic version of the Boolean GRN
In order to extend the Boolean Network into a discrete
stochastic model and then study the properties of its asso-
ciated EL, the so–called Stochasticity In Nodes model
was implemented following [13, 17, 84]. In this model,
a constant probability of error ξ is introduced for the
deterministic Boolean functions. In other words, at each
time step, each gene “disobeys” its Boolean function with
probability ξ . Formally:
Pxi(t+1)
[
Fi
(xregi(t)
)] = 1 − ξ , (2)
Pxi(t+1)
[
1 − Fi
(xregi(t)
)] = ξ . (3)
The probability that the value of the now random vari-
able xi(t+ 1) is determined or not by its associated logical
function Fi(xregi(t)) is 1 − ξ or ξ , respectively.
Attractor Transition Probability Estimation
An attractor transition probability matrix  with compo-
nents:
πij = P
(
At+1 = j|At = i
)
, (4)
representing the probability that an attractor j is reached
from an attractor i, was estimated by numerical simulation
following [13]. Specifically, for each network state i in the
state space (2n) a stochastic one–step transition was simu-
lated a large number of times (≈ 10, 000). The probability
of transition from an attractor i to an attractor j was then
estimated as the frequency of times the states belonging
to the basin of the attractor i were stochastically mapped
into a state within the basin of the attractor j.
Following the Discrete Time Markov Chains [99] the-
oretical framework, the estimated transition probability
matrix was integrated into a dynamic equation for the
probability distribution:
PA(t + 1) = PA(t), (5)
where PA(t) is the probability distribution over the attrac-
tors at time t, and  is the transition probability matrix
(Additional file 4: Table S1). This equation was then iter-
ated to simulate the temporal evolution of the probability
distribution over the attractors starting from a specific
initial probability distribution (Fig. 3a).
Attractor relative stability and global ordering analyses
In addition to the calculation of the most probable tempo-
ral cell–fate pattern [13], a discrete stochastic GRNmodel
enables the study of the ease for transitioning from one
attractor to another [91]. Specifically, a transition barrier
in the EL epitomizes the ease for transitioning from one
attractor to another. The ease of transitions, in turn, offers
a notion of relative stability. It has recently been proposed
that the GRN has a consistent global ordering of all cell
attractors and intermediate transient states which can be
uncovered by measuring the relative stability of all the
attractors of a Boolean GRN [85, 91]. Here, the relative
stability of each one of the cell states were defined based
on theMFPT. Specifically, a relative stability matrixMwas
calculated which reflects the transition barrier between
any two states based on the MFPT. Here, the MFPT was
numerically estimated. Using the transition probabilities
among attractors, a large number sample paths of a finite
Markov chain were simulated. The MFPT from attrac-
tor i to attractor j corresponds to the averaged value of
the number of steps taken to visit attractor j for the fist
time, given that the entire probability mass was initially
localized at the attractor i. The average is taken over the
realizations. Following [91], based on the MFPT values a
net transition rate between attractor i and j can be defined
as follows:
di,j = 1MFPTi,j −
1
MFPTj,i
. (6)
This quantity effectively measures the ease of transition
as a net probability flow, and is shown for our GRN in
Additional file 4: Table S2. For all the calculation involving
stochasticity, the robustness of the results was assessed by
taking three different values for the probability of error
(0.01, 0.05, 0.1). Stability of the results was assessed by
manually changing the number of simulated samples until
results become stable.
The consistent global ordering of all attractors uncov-
ered with the core GRN was defined based on the formula
proposed in [85]. Briefly, the consistent global ordering
of the attractors is given by the attractor permutation
in which all transitory net transition rates from an ini-
tial attractor to a final attractor are positive. This is
schematically represented in Fig. 3b. Calculated transition
probabilities, MFPT, and net transition rate matrices are
included in Additional file 4: Table S1, S2, and S3, respec-
tively. R source code implementing all the calculations and
analyses is available upon request.
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